- The Hong Kong stock market closed higher on August 20, with the Hang Seng Index up 203 pts or 0.8% at 25,698 and a total turnover of HKD 269.119 billion.
- KUAISHOU-W plunged 11.01% as its 2Q adjusted profit slid 30.3% YoY, while SBP GROUP surged 12.53% following a better-than-expected interim profit report.
- mRNA concept stocks rallied significantly after Moderna's cancer vaccine breakthrough, driving strong gains in related pharmaceutical firms like EVEREST MED and CANSINOBIO.
- At the midday close, the Hang Seng Index rose 291 points to reach 25,786, while the Hang Seng Tech Index increased by 72 points to 4,754.
- Major heavyweights such as XIAOMI, BABA, and TENCENT recorded solid gains alongside broader market movements.
- Stocks including WUXI BIO, WUXI APPTEC, BEIGENE, OOIL, and TINGYI hit new highs during the trading session.
- Kailera Therapeutics trades 29 % below its IPO high while holding $1.17 billion in cash and a $42 analyst consensus price target.
- Merck and Novo Nordisk emerge as natural buyers for Kailera's GLP - 1 pipeline due to impending revenue challenges and market defense needs.
- Any potential acquirer will secure global rights across the U.S., Europe, and Japan while inheriting significant financial obligations.
- At the midday close, the Hang Seng Index rose 405 pts or 1.6% to 25,521, while the Hang Seng Tech Index increased 94 pts or 2.0% to 4,802.
- Major tech heavyweights and index constituents recorded solid gains, including SMIC advancing over 7% and Tencent climbing 1.5%.
- Stocks such as WUXI APPTEC, ABLE DIGITAL, and SITC hit new highs during the trading session.